Jump Financial, LLC Precision Biosciences Inc Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$1.15 - $3.34 $11,613 - $33,730
10,099 New
10,099 $16,000
Q3 2021

Nov 12, 2021
SELL
$9.18 - $14.15 $728,892 - $1.12 Million
-79,400 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$8.07 - $12.52 $486,201 - $754,304
60,248 Added 314.58%
79,400 $994,000
Q1 2021

May 17, 2021
BUY
$8.57 - $15.79 $164,132 - $302,410
19,152 New
19,152 $198,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email